Investor mix
5 investors on record; lead investors include Oceanpine Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 80% |
| Other / undisclosed | 1 | 20% |
Developer of small molecules of drugs for cancer immunotherapy
5 investors on record; lead investors include Oceanpine Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 80% |
| Other / undisclosed | 1 | 20% |